Optimal testing strategies for incidental anti-mitochondrial M2 antibody-positive patients [0.03%]
偶然发现抗线粒体M2抗体阳性患者的最优检测方案
Kristina Emsell-Needham,Sujoy Khan
Kristina Emsell-Needham
Predicting fibrosis progression in non-alcoholic fatty liver disease patients using the FAST Score: A paired biopsy study [0.03%]
使用FAST评分预测非酒精性脂肪肝疾病患者的纤维化进展：一项配对活检研究
Nisanur Sariyar,Haluk Tarik Kani,Cigdem Ataizi Celikel et al.
Nisanur Sariyar et al.
Background and aim: This study aimed to investigate the predictive value of various non-invasive scores for identifying the progression of hepatic fibrosis over time in patients with Non-Alcoholic Fatty Liver Disease (NAF...
Vibration-controlled transient elastography for non-invasive screening of liver fibrosis and steatosis in Turkish patients with psoriasis: A cross-sectional study [0.03%]
振动控制瞬时弹性成像技术在土耳其银屑病患者中对肝纤维化和脂肪变性进行无创筛查的横断面研究
Ahsen Nihal Aksoy,Burak Hanci,Mehmet Furkan Baskent et al.
Ahsen Nihal Aksoy et al.
Background and aim: The prevalence of fibrosis and steatosis in patients with psoriasis, as determined by vibration-controlled transient elastography (VCTE), has not been evaluated in Turkiye to date. The present cross-se...
Correlation between ultrasonography and MR proton density fat fraction techniques in evaluating the severity of liver steatosis [0.03%]
超声与磁共振质子密度脂肪分数技术在评价肝脏脂肪变严重程度中的相关性研究
Betul Kizildag,Murat Baykara,Nursel Yurttutan et al.
Betul Kizildag et al.
Background and aim: To investigate the relationship between ultrasonography (US) and magnetic resonance (MR) proton density fat fraction (PDFF) techniques, using the modified DIXON method, in determining the severity of l...
Addressing the looming epidemic of metabolic dysfunction-associated steatotic liver disease in Pakistan: A call for action [0.03%]
应对巴基斯坦与代谢功能障碍相关的肝病流行病：行动呼吁
Lubna Kamani,Adeel Rahat,Yusuf Yilmaz
Lubna Kamani
Methiye Mancak,Dudu Altintas,Yasemin Balaban et al.
Methiye Mancak et al.
The liver is the main organ for metabolic and detoxification reactions in the body. Therefore, its diseases can be associated with both metabolic disorders, such as insulin resistance, obesity, diabetes, or dyslipidemia, and exogenous insul...
Kadir Intas
Kadir Intas
Herbal medicines are widely used worldwide to treat minor ailments and prevent disease. Scotch pine (Pinus sylvestris) has many medicinal applications but is most well-known for its antiseptic properties and beneficial effects on the respir...
Case Reports
Hepatology forum. 2024 Jan 16;5(1):47-48. DOI:10.14744/hf.2022.2022.0046 2024
Effect of probiotics supplementation on liver stiffness and steatosis in patients with NAFLD [0.03%]
补充益生菌对非酒精性脂肪肝病患者肝脏硬度和脂肪变性的影响
Shahinul Alam,Pallab Kumar Datta,Mahabubul Alam et al.
Shahinul Alam et al.
Background and aim: To compare the effects of probiotics on liver stiffness and steatosis in obese and non-obese patients with nonalcoholic fatty liver disease (NAFLD),the pragmatic clinical trial included 50 obese body m...
EP-01: Association of genetic polymorphisms of OATP with susceptibility to hepatocellular carcinoma in hepatitis C patients who achieved SVR by direct acting antivirals [0.03%]
DAAs治愈的丙型肝炎患者中OATP基因多态性与肝细胞癌易感性的关联研究
Zuhal Mert Altintas,Serkan Yaras,Engin Altintas
Zuhal Mert Altintas
OBJECTIVES: Simeprevir, daclatasvir, ledipasvir, paritaprevir and ritonavir are all substrates and inhibitors of the organic anion transporting polypeptide (OATP1B1 transporter, whereas sofosbuvir, ombitasvir and dasabuvir are not substrate...
Case Reports
Hepatology forum. 2021 Jan 30;2(Suppl 1):1-25. DOI: 2021
TASL Practice Guidance on the Clinical Assessment and Management of Patients with Nonalcoholic Fatty Liver Disease [0.03%]
非酒精性脂肪肝病的临床评估和管理实践指南
Yusuf Yilmaz,Mujdat Zeybel,Gupse Adali et al.
Yusuf Yilmaz et al.
Nonalcoholic fatty liver disease (NAFLD) is a multisystem disease and is significantly associated with obesity, insulin resistance, type 2 diabetes mellitus, metabolic syndrome, and cardiovascular disease. NAFLD has become the most prevalen...